Serum tumor markers in thyroid diseases
Journal Title: Міжнародний ендокринологічний журнал - Year 2019, Vol 15, Issue 2
Abstract
The article highlights the role of serum tumor markers in the diagnosis and treatment of thyroid diseases, primarily various forms of cancer. Clinical indications for the prescription and current recommendations for evaluating the results of thyroglobulin, calcitonin, and carcinoembryonic antigen determination are systematized. Prospects for the use of procalcitonin, chromogranin A tests, as well as individual molecular genetic studies are presented.
Authors and Affiliations
R. D. Makar, V. I. Vovk, I. M. Pavlovsky
Keywords
Related Articles
- EP ID EP605233
- DOI 10.22141/2224-0721.15.2.2019.166110
- Views 49
- Downloads 0
Features of Some Hormonal Parameters in Patients with Perinatal Losses
The presence of mixed urogenital infections during pregnancy leads to violations in mother’s body: changes of homeostasis, depression of the immune response, induction of the autoimmune processes resulting in reduced res...
Features of nephropathy in obese patients with type 2 diabetes mellitus
Background. The article describes the results of the studies of diabetic nephropathy in obese patients with type 2 diabetes mellitus (DM). The aim of the study is to investigate the combination of obesity and renal patho...
Substantiation for Approaches to Treatment of Latent Autoimmune Diabetes in Adults
The objective of this study was to substantiate the approaches to the treatment of latent autoimmune diabetes in adults on the basis of a comprehensive clinical examination of patients with this form of the disease. Rese...
Citoflavin® In Discirculatory Encephalopathy Treatment of Type 2 Diabetic Patients: Experience of Use
Results of Cytoflavin® use for the treatment of dyscirculatory encephalopathy in type 2 diabetic 42 patients are described in this article.
From Epidemy of Obesity to Epidemy of Diabetes Mellitus
.